Guwahati, August 7: US pharmaceutical giant Johnson & Johnson's single-dose COVID-19 vaccine has received emergency use approval in India. It has been informed through a tweet by the Union Health Minister Mansukh Mandaviya.
"India expands its vaccine basket! Johnson and Johnson's single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines. This will further boost our nation's collective fight against," he tweeted on Saturday afternoon.
The shot will be brought to India through a supply agreement with homegrown vaccine maker Biological E Limited.
"We are pleased to announce that on 7th August 2021, the Government of India issued Emergency Use Authorization (EUA) for the Johnson & Johnson COVID-19 single-dose vaccine in India, to prevent COVID in individuals 18 years of age and older," a Johnson & Johnson India spokesperson said.
With this, India has five Covid vaccines which have been given emergency use approval. The other four are Serum Institute's Covishield, Bharat Biotech's Covaxin, Russia's Sputnik V and Moderna.